BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19072223)

  • 1. Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics.
    Dodds ED; Seipert RR; Clowers BH; German JB; Lebrilla CB
    J Proteome Res; 2009 Feb; 8(2):502-12. PubMed ID: 19072223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site determination of protein glycosylation based on digestion with immobilized nonspecific proteases and Fourier transform ion cyclotron resonance mass spectrometry.
    Clowers BH; Dodds ED; Seipert RR; Lebrilla CB
    J Proteome Res; 2007 Oct; 6(10):4032-40. PubMed ID: 17824634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-Specific Protein N- and O-Glycosylation Analysis by a C18-Porous Graphitized Carbon-Liquid Chromatography-Electrospray Ionization Mass Spectrometry Approach Using Pronase Treated Glycopeptides.
    Stavenhagen K; Plomp R; Wuhrer M
    Anal Chem; 2015 Dec; 87(23):11691-9. PubMed ID: 26536155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoproteomics: A Balance between High-Throughput and In-Depth Analysis.
    Yang Y; Franc V; Heck AJR
    Trends Biotechnol; 2017 Jul; 35(7):598-609. PubMed ID: 28527536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein glycosylation analyzed by normal-phase nano-liquid chromatography--mass spectrometry of glycopeptides.
    Wuhrer M; Koeleman CA; Hokke CH; Deelder AM
    Anal Chem; 2005 Feb; 77(3):886-94. PubMed ID: 15679358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave-assisted nonspecific proteolytic digestion and controlled methylation for glycomics applications.
    Liu X; Chan K; Chu IK; Li J
    Carbohydr Res; 2008 Nov; 343(17):2870-7. PubMed ID: 18768173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Spectrometry-Based Chemical and Enzymatic Methods for Global Analysis of Protein Glycosylation.
    Xiao H; Suttapitugsakul S; Sun F; Wu R
    Acc Chem Res; 2018 Aug; 51(8):1796-1806. PubMed ID: 30011186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in mass spectrometry driven O-glycoproteomics.
    Levery SB; Steentoft C; Halim A; Narimatsu Y; Clausen H; Vakhrushev SY
    Biochim Biophys Acta; 2015 Jan; 1850(1):33-42. PubMed ID: 25284204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pronase-immobilized enzyme reactor: an approach for automation in glycoprotein analysis by LC/LC-ESI/MSn.
    Temporini C; Perani E; Calleri E; Dolcini L; Lubda D; Caccialanza G; Massolini G
    Anal Chem; 2007 Jan; 79(1):355-63. PubMed ID: 17194161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards structure-focused glycoproteomics.
    Chernykh A; Kawahara R; Thaysen-Andersen M
    Biochem Soc Trans; 2021 Feb; 49(1):161-186. PubMed ID: 33439247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High throughput quantitative glycomics and glycoform-focused proteomics of murine dermis and epidermis.
    Uematsu R; Furukawa J; Nakagawa H; Shinohara Y; Deguchi K; Monde K; Nishimura S
    Mol Cell Proteomics; 2005 Dec; 4(12):1977-89. PubMed ID: 16170054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intact glycopeptide characterization using mass spectrometry.
    Cao L; Qu Y; Zhang Z; Wang Z; Prytkova I; Wu S
    Expert Rev Proteomics; 2016 May; 13(5):513-22. PubMed ID: 27140194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in mass spectrometry-based glycoproteomics.
    Frost DC; Li L
    Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.
    Pan J; Hu Y; Sun S; Chen L; Schnaubelt M; Clark D; Ao M; Zhang Z; Chan D; Qian J; Zhang H
    Nat Commun; 2020 Dec; 11(1):6139. PubMed ID: 33262351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of N-glycosylation sites and site heterogeneity in glycoproteins.
    An HJ; Peavy TR; Hedrick JL; Lebrilla CB
    Anal Chem; 2003 Oct; 75(20):5628-37. PubMed ID: 14710847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoproteome study in myocardial lesions serum by integrated mass spectrometry approach: preliminary insights.
    Carpentieri A; Giangrande C; Pucci P; Amoresano A
    Eur J Mass Spectrom (Chichester); 2010; 16(1):123-49. PubMed ID: 20065524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel Determination of Polypeptide and Oligosaccharide Connectivities by Energy-Resolved Collison-Induced Dissociation of Protonated O-Glycopeptides Derived from Nonspecific Proteolysis.
    Kelly MI; Dodds ED
    J Am Soc Mass Spectrom; 2020 Mar; 31(3):624-632. PubMed ID: 32126781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites.
    Alvarez-Manilla G; Atwood J; Guo Y; Warren NL; Orlando R; Pierce M
    J Proteome Res; 2006 Mar; 5(3):701-8. PubMed ID: 16512686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
    Thaysen-Andersen M; Packer NH
    Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins.
    Ohyama Y; Nakajima K; Renfrow MB; Novak J; Takahashi K
    Expert Rev Proteomics; 2020 Apr; 17(4):275-296. PubMed ID: 32406805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.